Report Detail

Request for Sample of this report

Chemical & Material Global Irbesartan API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4638814
    • |
  • 24 October, 2025
    • |
  • Global
    • |
  • 94 Pages
    • |
  • GIR
    • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Irbesartan API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Irbesartan is a nonpeptide angiotensin II antagonist with antihypertensive activity. Irbesartan selectively and competitively blocks the binding of angiotensin II to the angiotensin I receptor. Angiotensin II stimulates aldosterone synthesis and secretion by adrenal cortex, which decreases the excretion of sodium and increases the excretion of potassium. Angiotensin II also acts as a vasoconstrictor in vascular smooth muscle.
This report is a detailed and comprehensive analysis for global Irbesartan API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Irbesartan API market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Irbesartan API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Irbesartan API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Irbesartan API market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Irbesartan API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Irbesartan API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Dr. Reddy’s Laboratories Ltd., Tecoland Corporation, Teva API, Divis Laboratories Ltd., Rundu Pharma, Apeloa Pharmaceutical Co., Ltd., CTX Lifesciences, Unichem Laboratories Limited, Zhejiang Huahai Pharmaceuticals Co., Ltd, Smilax Laboratories Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Irbesartan API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥98%
Purity<98%
Market segment by Application
Irbesartan Tablets
Others
Major players covered
Dr. Reddy’s Laboratories Ltd.
Tecoland Corporation
Teva API
Divis Laboratories Ltd.
Rundu Pharma
Apeloa Pharmaceutical Co., Ltd.
CTX Lifesciences
Unichem Laboratories Limited
Zhejiang Huahai Pharmaceuticals Co., Ltd
Smilax Laboratories Limited
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Irbesartan API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Irbesartan API, with price, sales quantity, revenue, and global market share of Irbesartan API from 2020 to 2025.
Chapter 3, the Irbesartan API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Irbesartan API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Irbesartan API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Irbesartan API.
Chapter 14 and 15, to describe Irbesartan API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Irbesartan API Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Purity≥98%
    • 1.3.3 Purity<98%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Irbesartan API Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Irbesartan Tablets
    • 1.4.3 Others
  • 1.5 Global Irbesartan API Market Size & Forecast
    • 1.5.1 Global Irbesartan API Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Irbesartan API Sales Quantity (2020-2031)
    • 1.5.3 Global Irbesartan API Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Dr. Reddy’s Laboratories Ltd.
    • 2.1.1 Dr. Reddy’s Laboratories Ltd. Details
    • 2.1.2 Dr. Reddy’s Laboratories Ltd. Major Business
    • 2.1.3 Dr. Reddy’s Laboratories Ltd. Irbesartan API Product and Services
    • 2.1.4 Dr. Reddy’s Laboratories Ltd. Irbesartan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
  • 2.2 Tecoland Corporation
    • 2.2.1 Tecoland Corporation Details
    • 2.2.2 Tecoland Corporation Major Business
    • 2.2.3 Tecoland Corporation Irbesartan API Product and Services
    • 2.2.4 Tecoland Corporation Irbesartan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Tecoland Corporation Recent Developments/Updates
  • 2.3 Teva API
    • 2.3.1 Teva API Details
    • 2.3.2 Teva API Major Business
    • 2.3.3 Teva API Irbesartan API Product and Services
    • 2.3.4 Teva API Irbesartan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Teva API Recent Developments/Updates
  • 2.4 Divis Laboratories Ltd.
    • 2.4.1 Divis Laboratories Ltd. Details
    • 2.4.2 Divis Laboratories Ltd. Major Business
    • 2.4.3 Divis Laboratories Ltd. Irbesartan API Product and Services
    • 2.4.4 Divis Laboratories Ltd. Irbesartan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Divis Laboratories Ltd. Recent Developments/Updates
  • 2.5 Rundu Pharma
    • 2.5.1 Rundu Pharma Details
    • 2.5.2 Rundu Pharma Major Business
    • 2.5.3 Rundu Pharma Irbesartan API Product and Services
    • 2.5.4 Rundu Pharma Irbesartan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Rundu Pharma Recent Developments/Updates
  • 2.6 Apeloa Pharmaceutical Co., Ltd.
    • 2.6.1 Apeloa Pharmaceutical Co., Ltd. Details
    • 2.6.2 Apeloa Pharmaceutical Co., Ltd. Major Business
    • 2.6.3 Apeloa Pharmaceutical Co., Ltd. Irbesartan API Product and Services
    • 2.6.4 Apeloa Pharmaceutical Co., Ltd. Irbesartan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Apeloa Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.7 CTX Lifesciences
    • 2.7.1 CTX Lifesciences Details
    • 2.7.2 CTX Lifesciences Major Business
    • 2.7.3 CTX Lifesciences Irbesartan API Product and Services
    • 2.7.4 CTX Lifesciences Irbesartan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 CTX Lifesciences Recent Developments/Updates
  • 2.8 Unichem Laboratories Limited
    • 2.8.1 Unichem Laboratories Limited Details
    • 2.8.2 Unichem Laboratories Limited Major Business
    • 2.8.3 Unichem Laboratories Limited Irbesartan API Product and Services
    • 2.8.4 Unichem Laboratories Limited Irbesartan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Unichem Laboratories Limited Recent Developments/Updates
  • 2.9 Zhejiang Huahai Pharmaceuticals Co., Ltd
    • 2.9.1 Zhejiang Huahai Pharmaceuticals Co., Ltd Details
    • 2.9.2 Zhejiang Huahai Pharmaceuticals Co., Ltd Major Business
    • 2.9.3 Zhejiang Huahai Pharmaceuticals Co., Ltd Irbesartan API Product and Services
    • 2.9.4 Zhejiang Huahai Pharmaceuticals Co., Ltd Irbesartan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Zhejiang Huahai Pharmaceuticals Co., Ltd Recent Developments/Updates
  • 2.10 Smilax Laboratories Limited
    • 2.10.1 Smilax Laboratories Limited Details
    • 2.10.2 Smilax Laboratories Limited Major Business
    • 2.10.3 Smilax Laboratories Limited Irbesartan API Product and Services
    • 2.10.4 Smilax Laboratories Limited Irbesartan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Smilax Laboratories Limited Recent Developments/Updates

3 Competitive Environment: Irbesartan API by Manufacturer

  • 3.1 Global Irbesartan API Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Irbesartan API Revenue by Manufacturer (2020-2025)
  • 3.3 Global Irbesartan API Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Irbesartan API by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Irbesartan API Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Irbesartan API Manufacturer Market Share in 2024
  • 3.5 Irbesartan API Market: Overall Company Footprint Analysis
    • 3.5.1 Irbesartan API Market: Region Footprint
    • 3.5.2 Irbesartan API Market: Company Product Type Footprint
    • 3.5.3 Irbesartan API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Irbesartan API Market Size by Region
    • 4.1.1 Global Irbesartan API Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Irbesartan API Consumption Value by Region (2020-2031)
    • 4.1.3 Global Irbesartan API Average Price by Region (2020-2031)
  • 4.2 North America Irbesartan API Consumption Value (2020-2031)
  • 4.3 Europe Irbesartan API Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Irbesartan API Consumption Value (2020-2031)
  • 4.5 South America Irbesartan API Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Irbesartan API Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Irbesartan API Sales Quantity by Type (2020-2031)
  • 5.2 Global Irbesartan API Consumption Value by Type (2020-2031)
  • 5.3 Global Irbesartan API Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Irbesartan API Sales Quantity by Application (2020-2031)
  • 6.2 Global Irbesartan API Consumption Value by Application (2020-2031)
  • 6.3 Global Irbesartan API Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Irbesartan API Sales Quantity by Type (2020-2031)
  • 7.2 North America Irbesartan API Sales Quantity by Application (2020-2031)
  • 7.3 North America Irbesartan API Market Size by Country
    • 7.3.1 North America Irbesartan API Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Irbesartan API Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Irbesartan API Sales Quantity by Type (2020-2031)
  • 8.2 Europe Irbesartan API Sales Quantity by Application (2020-2031)
  • 8.3 Europe Irbesartan API Market Size by Country
    • 8.3.1 Europe Irbesartan API Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Irbesartan API Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Irbesartan API Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Irbesartan API Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Irbesartan API Market Size by Region
    • 9.3.1 Asia-Pacific Irbesartan API Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Irbesartan API Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Irbesartan API Sales Quantity by Type (2020-2031)
  • 10.2 South America Irbesartan API Sales Quantity by Application (2020-2031)
  • 10.3 South America Irbesartan API Market Size by Country
    • 10.3.1 South America Irbesartan API Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Irbesartan API Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Irbesartan API Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Irbesartan API Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Irbesartan API Market Size by Country
    • 11.3.1 Middle East & Africa Irbesartan API Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Irbesartan API Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Irbesartan API Market Drivers
  • 12.2 Irbesartan API Market Restraints
  • 12.3 Irbesartan API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Irbesartan API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Irbesartan API
  • 13.3 Irbesartan API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Irbesartan API Typical Distributors
  • 14.3 Irbesartan API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Irbesartan API. Industry analysis & Market Report on Irbesartan API is a syndicated market report, published as Global Irbesartan API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Irbesartan API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo